Fosaprepitant Injection, Powder, Lyophilized, For Solution
Product Images NDC 16714-248

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Fosaprepitant (NDC 16714-248). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Fosaprepitantinjcont (Fosaprepitantinjcont)

Fosaprepitantinjcont (Fosaprepitantinjcont)
Fosaprepitant is a lyophilized powder that is stored in a single-dose vial and used for injection. Each vial contains 0 mg of the drug, and any unused portions should be discarded. The drug should be stored in a refrigerator between 2°C to 8°C. Once the drug is reconstituted, it can be stored at ambient room temperature for 24 hours or below 25°C. The usual dosage should be determined by consulting the prescribing information. The drug is sterile and intended for intravenous use only after reconstitution and dilution. The manufacturer is Northstar Rx LLC, based in Memphis, TN, and the drug is manufactured by Aspiro Pharma Limited in Telangana, India. The lot number and expiration date are printed on each vial, and it is labeled with a 16x12mm batch code area.*
FDA Label Image

Fosaprepitantinjstructure (Fosaprepitantinjstructure)

Fosaprepitantinjstructure (Fosaprepitantinjstructure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.